- Home
- ICCC vs ISPO Comparison
ICCC vs ISPO Comparison
Compare ICCC & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- ISPO
- Stock Information
- Founded
- ICCC 1982
- ISPO 2010
- Country
- ICCC United States
- ISPO United States
- Employees
- ICCC N/A
- ISPO N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- ISPO Blank Checks
- Sector
- ICCC Health Care
- ISPO Finance
- Exchange
- ICCC Nasdaq
- ISPO Nasdaq
- Market Cap
- ICCC 48.3M
- ISPO 53.5M
- IPO Year
- ICCC 1987
- ISPO N/A
- Fundamental
- Price
- ICCC $5.50
- ISPO $3.52
- Analyst Decision
- ICCC
- ISPO
- Analyst Count
- ICCC 0
- ISPO 0
- Target Price
- ICCC N/A
- ISPO N/A
- AVG Volume (30 Days)
- ICCC 39.3K
- ISPO 23.8K
- Earning Date
- ICCC 05-14-2025
- ISPO 05-06-2025
- Dividend Yield
- ICCC N/A
- ISPO N/A
- EPS Growth
- ICCC N/A
- ISPO N/A
- EPS
- ICCC N/A
- ISPO N/A
- Revenue
- ICCC $26,493,169.00
- ISPO $279,855,000.00
- Revenue This Year
- ICCC N/A
- ISPO N/A
- Revenue Next Year
- ICCC N/A
- ISPO $148.70
- P/E Ratio
- ICCC N/A
- ISPO N/A
- Revenue Growth
- ICCC 51.63
- ISPO N/A
- 52 Week Low
- ICCC $3.34
- ISPO $3.11
- 52 Week High
- ICCC $5.82
- ISPO $9.31
- Technical
- Relative Strength Index (RSI)
- ICCC 59.13
- ISPO 36.23
- Support Level
- ICCC $4.63
- ISPO $3.36
- Resistance Level
- ICCC $5.72
- ISPO $4.04
- Average True Range (ATR)
- ICCC 0.42
- ISPO 0.32
- MACD
- ICCC 0.05
- ISPO -0.04
- Stochastic Oscillator
- ICCC 79.82
- ISPO 13.47
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.